Your browser doesn't support javascript.
loading
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
Saunders, Kevin O; Pardi, Norbert; Parks, Robert; Santra, Sampa; Mu, Zekun; Sutherland, Laura; Scearce, Richard; Barr, Maggie; Eaton, Amanda; Hernandez, Giovanna; Goodman, Derrick; Hogan, Michael J; Tombacz, Istvan; Gordon, David N; Rountree, R Wes; Wang, Yunfei; Lewis, Mark G; Pierson, Theodore C; Barbosa, Chris; Tam, Ying; Matyas, Gary R; Rao, Mangala; Beck, Zoltan; Shen, Xiaoying; Ferrari, Guido; Tomaras, Georgia D; Montefiori, David C; Weissman, Drew; Haynes, Barton F.
Afiliação
  • Saunders KO; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Pardi N; Department of Surgery, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Parks R; Department of Molecular Genetics and Microbiology, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Santra S; Department of Immunology, Duke School of Medicine, Durham, NC, USA. kevin.saunders@duke.edu.
  • Mu Z; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Sutherland L; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Scearce R; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Barr M; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Eaton A; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Hernandez G; Department of Immunology, Duke School of Medicine, Durham, NC, USA.
  • Goodman D; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Hogan MJ; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Tombacz I; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Gordon DN; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Rountree RW; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Wang Y; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Lewis MG; Department of Surgery, Duke School of Medicine, Durham, NC, USA.
  • Pierson TC; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Barbosa C; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Tam Y; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Matyas GR; Department of Surgery, Duke School of Medicine, Durham, NC, USA.
  • Rao M; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Beck Z; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Shen X; Bioqual Inc., Rockville, Maryland, USA.
  • Ferrari G; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Tomaras GD; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Montefiori DC; Duke Human Vaccine Institute, Duke School of Medicine, Durham, NC, USA.
  • Weissman D; Department of Medicine, Duke School of Medicine, Durham, NC, USA.
  • Haynes BF; Bioqual Inc., Rockville, Maryland, USA.
NPJ Vaccines ; 6(1): 136, 2021 Nov 06.
Article em En | MEDLINE | ID: mdl-34743171
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: NPJ Vaccines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos